Amsterdam 2013 Programme Satellite Meetings Registration Exhibition Virtual Exhibition Hotels Visa Letter Invitation
Search Abstracts by author or title
(results will display both Free Papers & Poster)
Back to Freepaper Session

Posterior chamber toric phakic intraocular lens implantation for the management of anisometropia with astigmatism and amblyopia

Session Details

Session Title: Phakic IOL Implantation II

Session Date/Time: Wednesday 09/10/2013 | 08:00-10:30

Paper Time: 08:44

Venue: E104-105 (First Floor)

First Author: : T.Althomali SAUDI ARABIA

Co Author(s): :                  

Abstract Details

Purpose:

Posterior chamber toric phakic intraocular lens implantation for the management of anisometropia with astigmatism and amblyopia

Setting:

Taif university,Saudi Arabia

Methods:

Six eyes of 6 amblyopic patients, aged 5 to 15 years underwent toric phakic IOL implantation for refractory anisometropic amblyopia. Preoperative and postoperative clinical evaluation included slit-lamp microscopy, visual acuity, anterior/posterior segment examination and cycloplegic refraction.

Results:

After a mean follow-up of ~23 months, mean SEq cycloplegic refraction improved from -10.21 ± 4.62 D (range -7.5 D to -19.5 D) preoperatively to -0.42 ± 0.39 (-0.625 to +0.125) D postoperatively. Preoperative CDVA ranged from 20/40 to 20/200 and postoperative from 20/20 to 20/60. Five of the 6 eyes gained >3 lines in CDVA with a maximum gain of 8 lines in one eye. One eye that showed an improvement of > 2 lines improved from 20/100 preoperatively to 20/60 postoperatively. No patients lost any line of visual acuity. No inflammatory reactions were observed and the toric pIOLs remained well centered with no rotation from the desired position.

Conclusions:

In children with refractory amblyopia due to anisometropia and astigmatism, implantation of toric pIOL may be a viable alternative to the traditional medical treatment with glasses and contact lens. However, longer follow-up is needed to evaluate the long-term risks and benefits.

Financial Interest:

NONE


loading Please wait while information is loading.